Re: Win or lose....one thing we know for sure
|
5
|
Resverlogix Corp.
|
Aug 31, 2019 07:55AM
|
Re: Win or lose....one thing we know for sure
|
4
|
Resverlogix Corp.
|
Aug 31, 2019 05:21PM
|
Re: Win or lose....one thing we know for sure
|
4
|
Resverlogix Corp.
|
Sep 02, 2019 11:43AM
|
Re: What we know and what we don't.....
|
4
|
Resverlogix Corp.
|
May 16, 2019 05:33PM
|
Re: What impact would a PR like this have?
|
4
|
Resverlogix Corp.
|
Jan 29, 2019 04:49PM
|
Re: What if
|
5
|
Resverlogix Corp.
|
Mar 06, 2019 01:05PM
|
Re: What else can RVX treat that we don’t know about yet?
|
6
|
Resverlogix Corp.
|
Mar 30, 2019 09:55PM
|
Re: What else can RVX treat that we don’t know about yet?
|
6
|
Resverlogix Corp.
|
Mar 31, 2019 08:22AM
|
Re: What else can RVX treat that we don’t know about yet?
|
5
|
Resverlogix Corp.
|
Mar 31, 2019 08:39AM
|
Re: Warrants
|
2
|
Resverlogix Corp.
|
Jun 30, 2017 05:17PM
|
Re: Warrants
|
1
|
Resverlogix Corp.
|
Jun 30, 2017 12:54PM
|
Re: Vitamin D and Omega 3 don’t preserve renal fxn in Type 2 DM
|
7
|
Resverlogix Corp.
|
Nov 12, 2019 11:06AM
|
Re: US Patent Application Publication filed Sept 16th by Resverlogix
|
5
|
Resverlogix Corp.
|
Sep 19, 2016 02:41PM
|
Re: Tweet
|
7
|
Resverlogix Corp.
|
Nov 16, 2019 02:15PM
|
Re: Total (MACE) Events?
|
4
|
Resverlogix Corp.
|
Jun 18, 2017 02:05PM
|
Re: Thoughts on PX: Calm down
|
6
|
Resverlogix Corp.
|
Mar 15, 2019 01:45PM
|
Re: Third Eye, AHA, US Listing
|
5
|
Resverlogix Corp.
|
Sep 11, 2019 04:18PM
|
Re: Successful CANTOS Inflammation Trial Supports Rationale for Resverlogix' Ongoing BETonMACE Trial
|
8
|
Resverlogix Corp.
|
Aug 29, 2017 04:55PM
|
Re: Sub-study Forest Plot
|
4
|
Resverlogix Corp.
|
Nov 16, 2019 03:00PM
|
Re: Speculation to chew on for the weekend....
|
3
|
Resverlogix Corp.
|
Sep 24, 2016 09:04AM
|